ArticleRadiology. Imaging cancer2026
A Self-Supervised Foundation Model Based on Three-Dimensional Chest CT Scans for Lung Cancer Diagnosis and Prognosis Prediction.
Article in Radiology. Imaging cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Machine Learning for Radiomics in Oncology: Challenges, Limitations, and Future Directions.Sensors (Basel, Switzerland) · 2026Article
- Advancing Lung Cancer Imaging with Self-Supervised Foundation Models.Radiology. Imaging cancer · 2026Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To develop a self-supervised chest CT foundation model and evaluate its performance in lung cancer clinical tasks. Materials and Methods In this retrospective multicenter study, the authors developed the Unified CT-Based Lung Cancer Imaging Foundation (UCLIF) model using self-supervised learning on 33 901 three-dimensional chest CT scans acquired between June 1958 and February 2019. The model was pretrained with a contrastive masked image modeling task and then fine-tuned for lung cancer histologic subtype classification, cancer staging, survival, and recurrence prediction using multicenter patient datasets. Histopathology, TNM stage, and follow-up outcomes served as reference standards. UCLIF was compared with mainstream deep learning and machine learning algorithms, and model performance was assessed by accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC); superiority was tested using the DeLong test. Results A total of 656 patients were included for downstream evaluation (mean age, 68.55 years ± 10.01 [SD]; 450 males). Compared with self-supervised pretraining on natural images or single tumor regions, UCLIF achieved superior performance (DeLong test,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.